Petter Veiby
Fortuna: 2 M $ al 31/08/2026
Fortuna: 2 M $ al 31/08/2026
Mr. Petter Veiby is a Chief Scientific Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at BiVictriX Therapeutics Plc.
Mr. Veiby was previously employed as a Senior Director by Takeda Oncology Co., a Senior Vice President-Business Development by Immunitas Therapeutics, Inc., a Head-Alliances by Zai Lab Ltd., and a Global Head-Biotherapeutics by Takeda Oncology Co.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/08/2026 | 104.952 ( 0,23 % ) | 2 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Fundador | 16/12/2022 |
| BIVICTRIX THERAPEUTICS PLC | Director/Miembro de la Junta | 01/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Director/Miembro de la Junta | 01/06/2023 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01/11/2022 |
| ZAI LAB LIMITED | Corporate Officer/Principal | 01/05/2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/03/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BiVictriX Therapeutics Plc
BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.